ERBB2 and breast cancer: There are three primary subtypes of breast cancer: triple-negative breast cancer (15%, where the tumors lack all three molecular markers), ERBB2-positive breast cancer (15–20%), and hormone-receptor-positive/human epidermal growth factor 2 (ERBB2)-negative (70% of patients) breast cancer [2].